Background and aims Systemic lupus erythematosus (SLE) is a seriously chronic autoimmune disease, which is characterised by a large number of autoantibodies and multiple organ damage. Skin lesion is one of the common clinical manifestations of lupus erythematosus, but its pathogenesis is not clear. IL-1 is a proinflammatory cytokine, the aim in this study is to investigate the role of IL-1 in the skin injury in SLE.
Methods We used IL-1 receptor deficient mice and other gene deficient mice to study the role of IL-1 in the lupus serum IgG -induced skin inflammation.
Results We found that the severity of skin lesion in IL-1 receptor deficient mice and caspase-1 deficient mice was reduced compared with that in wild type mice. IL-1 receptor deficiency suppressed the expression of FcγRI (CD64) and MHC class II (CD74), and increased the level of FcγRII (CD32) induced by lupus serum. IL-1 receptor deficiency also suppressed the lipid raft clustering and IFN-γ in T cells, and reduced IgG internalisation and presentation in macrophage, and decreased expression of MCP-1 and TNFa in monocytes. In addition, TNFa could promote the proliferation of kerationocytes.
Conclusions Our findings indicate that IL-1 plays an important role in skin lesions of lupus erythematosus. This study suggests IL-1 is a therapeutic target in skin lesions of systemic lupus erythematosus.
- © 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.